Form 4 for SYRE Spyre Therapeutics, Inc.
Accepted 2024-10-28 00:00:00 ET · period of report 2024-10-25 · accession 0001636282-24-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-10-28 | 2024-10-25 | SYRE | Albers Jeffrey W. | Dir | S - Sale | $36.43 | -300 | 34.1K | -0.9% | -$10.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-25 | S | D | 300 | $36.43 | 34,060 | I By Sessions LLC | — | — |